8-{4-[3-(1H-Indol-3-yl)-propyl]-piperazin-1-yl}-4H-benzo[1,4]oxazin-3-one

ID: ALA198069

Chembl Id: CHEMBL198069

PubChem CID: 11696788

Max Phase: Preclinical

Molecular Formula: C23H26N4O2

Molecular Weight: 390.49

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  O=C1COc2c(cccc2N2CCN(CCCc3c[nH]c4ccccc34)CC2)N1

Standard InChI:  InChI=1S/C23H26N4O2/c28-22-16-29-23-20(25-22)8-3-9-21(23)27-13-11-26(12-14-27)10-4-5-17-15-24-19-7-2-1-6-18(17)19/h1-3,6-9,15,24H,4-5,10-14,16H2,(H,25,28)

Standard InChI Key:  MKNKEMCPBIDCMA-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA198069

   8-{4-[3-(1H-Indol-3-yl)-propyl]-piperazin-1-yl}-4H-benzo[1,4]oxazin-3-one

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 390.49

Molecular Weight (Monoisotopic): 390.2056

AlogP: 3.25

#Rotatable Bonds: 5

Polar Surface Area: 60.60

Molecular Species: NEUTRAL

HBA: 4

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 11.58

CX Basic pKa: 8.34

CX LogP: 3.27

CX LogD: 2.28

Aromatic Rings: 3

Heavy Atoms: 29

QED Weighted: 0.70

Np Likeness Score: -0.86

References

1. Smid P, Coolen HK, Keizer HG, van Hes R, de Moes JP, den Hartog AP, Stork B, Plekkenpol RH, Niemann LC, Stroomer CN, Tulp MT, van Stuivenberg HH, McCreary AC, Hesselink MB, Herremans AH, Kruse CG..  (2005)  Synthesis, structure-activity relationships, and biological properties of 1-heteroaryl-4-[omega-(1H-indol-3-yl)alkyl]piperazines, novel potential antipsychotics combining potent dopamine D2 receptor antagonism with potent serotonin reuptake inhibition.,  48  (22): [PMID:16250644] [10.1021/jm050148z]

Source

Source(1):

• Scientific Literature